Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-21

FDA Approved: CITALOPRAM — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Cipla USA Inc. to market generic citalopram. This action confirms the availability of a generic citalopram produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citalopram (Citalopram hydrobromide)

Snippet

SUPPL AP for CITALOPRAM (CITALOPRAM)